Citation Impact
Citing Papers
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy
2004
Computed Tomography — An Increasing Source of Radiation Exposure
2007 Standout
Testicular Germ-Cell Cancer
1997 Standout
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
2004
Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs
1998
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
1995 Standout
Therapeutic Drug Monitoring in Oncology
1987
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
2009
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
High-dose methotrexate: a critical reappraisal.
1987
Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma
2007
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Drug-Induced Acute Pancreatitis
1989
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Paclitaxel (Taxol)
1995 Standout
SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial Sarcoma
1998
Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review
2012
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group
2005 StandoutNobel
High incidence of secondary brain tumours after radiotherapy and antimetabolites
1999
Soft-Tissue Sarcomas in Adults
2005 Standout
The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*
1996
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours
1991
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Apoptosis and cancer: the genesis of a research field
2009
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
1995
LONG-TERM SURVIVORS OF CHILDHOOD CANCER
1997
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Death receptors in chemotherapy and cancer
2004
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Structure-activity relationships of VP-16 analogues
1994
Male breast cancer
2006 Standout
Cardiotoxicity of Chemotherapeutic Agents
2000
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Limb salvage in musculoskeletal oncology
2003
Acute Pancreatitis
1994 Standout
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Neuroblastoma
2007 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease
1996
Neoadjuvant chemotherapy for osteosarcoma of the extremity
2001
Primary brain tumours in adults
2012 Standout
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Relationship Between Topotecan Systemic Exposure and Tumor Response in Human Neuroblastoma Xenografts
1998
A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses
2011
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
2009 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Epidemiology of Brain Tumors
2008
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
2007 StandoutNobel
Preservation of Fertility in Patients with Cancer
2009 Standout
Brain Tumors
2001 Standout
Late effects of childhood cancer therapy
2002
Genetic polymorphisms in sepsis
2005
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
2008
Epstein–Barr Virus Infection
2000 Standout
Cancer of the Ovary
2004 Standout
Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group
2010
A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors
2003
High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group
2003
Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy
1983
Association of CYP 3 A 4 genotype with treatment-related leukemia
1998
Single Center Experience of a New Intensive Induction Therapy for Ewing’s Family of Tumors: Feasibility, Toxicity, and Stem Cell Mobilization Properties
2003
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity
1986 Standout
Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
1982
Phase II Trial of the Anti-GD2Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma
2001
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
2003
Cytokine Storm
2020 Standout
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Treatment of Patients With EBV-Positive Relapsed Hodgkin's Disease
1998
A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC).
1995 StandoutNobel
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
2003 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Metabolism of oxazaphosphorines
1988
Second Malignancies After Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Therapy Versus Mastectomy
2000
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
1998
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Results of a Phase II Upfront Window of Pharmacokinetically Guided Topotecan in High-Risk Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor
2004
RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
2011 StandoutNobel
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of C B Pratt being referenced
Myeloid neoplasia in children treated for solid tumours
1990
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
1992
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study.
1993
Ifosfamide in pediatric malignant solid tumors
1989
Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study.
1993
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.
1998
Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors.
1990
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity.
1994
Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience.
1994
Ifosfamide, Fanconi's syndrome, and rickets.
1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
1991
Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors.
1994
Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia.
1996
Use of Investigational Drugs as Initial Therapy for Childhood Solid Tumors
1989
Breast masses in women treated for childhood cancer
1998
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
1995
Conduct of phase I trials in children with cancer.
1998
Phase I study of topotecan for pediatric patients with malignant solid tumors.
1994
Prognostic significance of apoptosis regulators in breast cancer.
1999
Phase II trial of ifosfamide in children with malignant solid tumors.
1987
Osteosarcoma studies at St. Jude Children’s Research Hospital from 1968 through 1990
1993
4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.
1975
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate.
1984
Phase I trial of mitoxantrone in children.
1985
Interpatient variability in oral (PO) absorption of topotecan (TPT) in children with relapsed solid tumors.
1996
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
1996
High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma.
1980
Pancreatitis following cisplatin: a case report.
1985